Zscaler: Moving Past The SaaSpocalypse, But Hasn't Caught Up To Fundamental Strength

Zscaler (ZS) is still down ~20% YTD and ~30% YoY, but the article reiterates a buy rating after strong fiscal results and robust bookings. It highlights accelerating ARR growth as evidence against prior fears of SaaS weakness and seat-driven churn. Overall, the update is supportive but framed more as valuation/positioning versus a new, market-wide catalyst.

Analysis

The market still treats ZS like a high-duration software name with fragile seat economics, but the operating read-through is more important: if bookings and ARR are inflecting together, that implies the product is taking budget share, not merely benefiting from price hikes. That favors a rerating versus slower-growing security peers because the equity has been priced as if growth is structurally capped; any proof that customers are consolidating around a secure-access platform should widen the valuation gap versus broader software rather than just lift the stock on sympathy.

Second-order, this is a negative signal for vendors exposed to point-product displacement and a positive one for security consolidation winners. A sustained ZS reacceleration pressures competitors that rely on incremental seat expansion or fragmented security stacks; it also argues against the blanket “SaaS churn” narrative that has been weighing on the whole group. The immediate move can continue for days, but the real catalyst path is 1-3 months of guide validation; if next-quarter ARR/billings sustain above revenue growth and deferred revenue quality holds, multiple expansion can extend for 6-18 months.

The contrarian risk is that this is a one-quarter catch-up after depressed expectations, not a new demand regime. What would falsify the thesis is any sign that ARR strength came from deal timing, channel stuffing, or unusually large commitments that do not convert into durable net retention. If the company stops showing consistent forward-booking momentum, the stock likely reverts to being a “cheap for a reason” software name rather than a re-accelerating compounder.

Key Decisions for Investors

• Buy ZS on pullbacks over the next 1-3 weeks; target a 15-20% rebound over 3 months if ARR and bookings remain above revenue growth, with a stop if management guides to re-acceleration fading next quarter.
• For investors wanting defined risk, use a 3-6 month ZS call spread instead of stock to express the rerating view; the setup improves if implied volatility stays elevated relative to the sector.
• Pair trade: long ZS / short IGV to isolate security-growth reacceleration from broader software beta; this is most attractive if software multiples continue to compress while ZS shows guide confidence.
• Set an alert for the next quarter’s billings, deferred revenue, and net retention: if any of those fail to confirm the ARR story, reduce exposure quickly because the thesis depends on durable bookings quality, not one-quarter execution.